Regenerx Biopharm In Financials

Regenerx Biopharm Stock Summary

Regenerx Biopharm competes with Fortress Biotech, Alpha Cognition, and Silo Pharma. RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland. REGENERX BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Regenerx Biopharm Key Financial Ratios

Regenerx Biopharm's financial ratios allow both analysts and investors to convert raw data from Regenerx Biopharm's financial statements into concise, actionable information that can be used to evaluate the performance of Regenerx Biopharm over time and compare it to other companies across industries.

Regenerx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Regenerx Biopharm's current stock value. Our valuation model uses many indicators to compare Regenerx Biopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Regenerx Biopharm competition to find correlations between indicators driving Regenerx Biopharm's intrinsic value. More Info.Regenerx Biopharm In is rated second in return on asset category among its peers. It is currently regarded as top stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Regenerx Biopharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Regenerx Biopharm's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Regenerx Biopharm Market Pulse

Along with financial statement analysis, the daily predictive indicators of Regenerx Biopharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Regenerx Biopharm In. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regenerx Biopharm In based on widely used predictive technical indicators. In general, we focus on analyzing Regenerx OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regenerx Biopharm's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.